FindTrial
Sign In

The Effect of Yashtyadi Kwath and Shunthyadi Pindi in the Management of Praklinna Vartma with special reference to Squamous Blepharitis

A Clinical Assessment to evaluate the Efficacy of Yashtyadi Kwath and Shunthyadi Pindi in the Management of Praklinna Vartma with special reference to Squamous Blepharitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044243
Enrollment
50
Registered
2022-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H010- Blepharitis

Interventions

None listed

Sponsors

Dr Akash Pralhad Gaikwad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients presenting with the clinical features of Praklinnavartma (Squamous Blepharitis) 2.Patient with in the age group between 18 to 60 years 3.Patients who are willing to undergo the respective treatment protocol.

Exclusion criteria

Exclusion criteria: Patients who are below 18 years and above 60 years are excluded. ï?¶ Pregnant women and lactating mother. ï?¶ Patients suffering from other systemic disease like Hypertension, Diabetes Mellitus, Tuberculosis and Asthma. ï?¶ Associated with psoriasis and other skin diseases. ï?¶ Patients suffering from other ocular disorders like Ptosis, Corneal ulcers, Follicular conjunctivitis, Purulent Conjunctivitis, Trichiasis, Multiple styes, Tumors etc.

Design outcomes

Primary

MeasureTime frame
Reduction in the symptoms like Itching, burning, lacrimation, scale formation, congestion & swelling of eyelidsTimepoint: 7 weeks—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Kavita Thorat

D Y Patil School Of Ayurveda, Nerul, Navi Mumbai

kavita.thorat@dypatil.edu9167219691

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026